Home › Trial NCT00365222
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
- Trial IDNCT00365222
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorH. Lee Moffitt Cancer Center and Research Institute
- Enrollment1
- Start date2006-07
- ConditionsGlioblastoma · Gliosarcoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.